BeiGene Correlations
BGNE Stock | USD 206.16 14.05 7.31% |
The current 90-days correlation between BeiGene and Incyte is 0.06 (i.e., Significant diversification). The correlation of BeiGene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
BeiGene Correlation With Market
Significant diversification
The correlation between BeiGene and DJI is 0.05 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding BeiGene and DJI in the same portfolio, assuming nothing else is changed.
BeiGene |
Moving together with BeiGene Stock
Moving against BeiGene Stock
0.52 | INAB | In8bio Inc | PairCorr |
0.5 | VTRS | Viatris | PairCorr |
0.6 | NBIX | Neurocrine Biosciences | PairCorr |
0.53 | MNMD | Mind Medicine | PairCorr |
0.45 | DXCM | DexCom Inc | PairCorr |
0.33 | MOLN | Molecular Partners | PairCorr |
0.32 | SIGA | SIGA Technologies | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between BeiGene Stock performing well and BeiGene Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze BeiGene's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ASND | 2.10 | (0.08) | (0.04) | 0.02 | 2.76 | 4.75 | 22.16 | |||
APLS | 2.51 | (0.25) | 0.00 | (0.26) | 0.00 | 4.48 | 15.97 | |||
AKRO | 2.37 | 0.13 | 0.07 | 0.19 | 2.66 | 5.23 | 13.37 | |||
BPMC | 1.81 | (0.09) | (0.02) | 0.04 | 2.58 | 4.90 | 14.28 | |||
IMAB | 3.72 | (0.47) | 0.00 | (0.21) | 0.00 | 7.83 | 30.63 | |||
KRYS | 1.82 | (0.17) | (0.05) | 0.01 | 2.13 | 4.45 | 12.05 | |||
IMVT | 2.05 | (0.24) | 0.00 | (0.12) | 0.00 | 3.77 | 17.16 | |||
MRTX | 2.24 | (0.50) | 0.00 | (0.67) | 0.00 | 4.02 | 16.13 | |||
INCY | 1.55 | 0.11 | 0.05 | 0.22 | 2.00 | 3.02 | 20.37 | |||
BMRN | 1.28 | (0.52) | 0.00 | (1.04) | 0.00 | 1.42 | 18.88 |
BeiGene Corporate Management
Chan Lee | General VP | Profile | |
Mi Zhou | Director Relations | Profile | |
Liza Heapes | Head Relations | Profile | |
Wang Lai | Global RD | Profile | |
Kevin Mannix | VP Relations | Profile |